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CASE REPORT 
RING ENHANCING INTRACRANIAL LESION RESPONDING TO ANTITUBERCULOUS TREATMENT IN 
AN HIV-INFECTED PATIENT
Daniela PELLEGRINO(1), Juliana GERHARDT(1), Fátima M.V. PORFÍRIO(1) Edgar DE BORTHOLI SANTOS(1), Rafi F. DAUAR(2),  
Augusto C. PENALVA DE OLIVEIRA(3) & José E. VIDAL(3,4)
SUMMARY
Cerebral tuberculomas constitute a major differential diagnosis of cerebral toxoplasmosis in human immunodeficiency virus (HIV)-
infected patients in developing countries. We report the case of a 34-year old woman co-infected with HIV and possible disseminated 
tuberculosis (hepatitis, lymphadenopathy, and pleural effusion) who presented a large and solitary intracranial mass lesion. Despite 
extensive diagnostic efforts, including brain, ganglionar, and liver biopsies, no definitive diagnosis was reached. However, a trial 
with first-line antituberculous drugs led to a significant clinical and radiological improvement. Atypical presentations of cerebral 
tuberculomas should always be considered in the differential diagnosis of intracranial mass lesions in HIV-infected patients and a 
trial with antituberculous drugs is a valuable strategy to infer the diagnosis in a subset of patients.
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INTRODUCTION
Central nervous system tuberculosis results in high mortality and 
morbidity in human immunodeficiency virus (HIV)-infected patients 
from South America4,7. Cerebral tuberculomas constitute the main 
differential diagnosis of cerebral toxoplasmosis in resource-limited 
settings8,9, including Brazil16. Here, we report an HIV-infected patient 
with a solitary and large intracranial mass and discuss the caveats of its 
diagnosis and treatment. 
CASE REPORT
A 34-year old woman was admitted to this hospital because of a 
two-week history of right side weakness and cognitive impairment. HIV 
infection had been diagnosed four months earlier, as well as a possible 
disseminated tuberculosis with pleural and ganglionar involvement. 
Her medication included stavudine, lamivudine, efavirenz, rifampicin, 
pyrazinamide, ethambutol, and streptomycin. 
This treatment was started in another facility, where poor 
adherence and hepatotoxicity secondary to isoniazid were reported. 
On physical examination, she presented peripheral lymphadenopathy, 
hepatoesplenomegaly, disorientation, decreased level of consciousness, 
right sided hemiparesis, right central facial paresis, and aphasia. Altered 
laboratory tests included hemoglobin 8.4 g/dL, platelets 41,000/mm3, 
aspartate aminotransferase (AST) 161 UI/L, alanine aminotransferase 
(ALT) 201 UI/L, and albumin 2.5 g/dL. IgG Toxoplasma gondii serology 
was positive. CD4+ T-cell count was 241 cells/mm3 and viral load 
was > 500,000 copies/mL. A tuberculin skin test was not performed. 
A chest X-ray showed mild bilateral pleural effusion. An abdominal 
ultrasonography revealed hepatosplenomegaly and retroperitoneal 
lymphadenopathy. A cerebral computed tomography (CT) scan showed 
an irregular, solitary large lesion in the left fronto-temporo-parietal 
region, with a thick ring-enhancing pattern and extensive perilesional 
edema. Empirical treatment for cerebral toxoplasmosis with clindamycin 
600 mg QID, pyrimethamine 50 mg QD, folinic acid 15 mg QD 
along with dexamethasone 4 mg QID was initiated. Antituberculous 
agents and HAART were maintained. Two weeks later, a new CT 
scan (Fig. 1A) showed an increase on the size of the cerebral lesion 
and the patient developed right hemiplegia. Cerebral toxoplasmosis 
treatment was discontinued but dexamethasone was maintained. As 
the patient presented a worsening of liver enzymes levels (AST 459 
IU/L, ALT 509 UI), rifampicin was switched to ofloxacin. Four weeks 
after admission, a magnetic resonance imaging (MRI) revealed a large 
expansive brain lesion with intermediate signal intensity and ring 
enhancement on T1-weighted image after gadolinium administration 
and with intermediate signal intensity on T2-weighted image (Fig. 2A 
and 2B). The lesion was hypointense on diffusion-weighted MRI (DWI), 
PELLEGRINO, D.; GERHARDT, J.; PORFÍRIO, F.M.V.; DE BORTHOLI SANTOS, E.; DAUAR, R.F.; PENALVA DE OLIVEIRA, A.C. & VIDAL, J.E. - Ring enhancing intracranial lesion 
responding to antituberculous treatment in an HIV-infected patient. Rev. Inst. Med. Trop. Sao Paulo, 52(5): 285-7, 2010.
286
Laboratory tests disclosed hemoglobin of 12.4 g/dL, platelets 
238,000/mm3, AST 88 UI/L, ALT 91 UI/L, and albumin 3.4 g/dL. Three 
months after admission, the patient was discharged using rifampin, 
isoniazid, tenofovir, lamivudine, and efavirenz. The switch from 
stavudine to tenofovir was performed in order to improve adherence with 
a once daily dosing regimen and better tolerability profile. Her CD4+ 
cell count was 427 cells/mm3 and her viral load was < 400 copies/mL. 
Fortunately, her post-discharge course has been uneventful and the patient 
remains with a mild residual right hemiparesis. 
DISCUSSION
Our report emphasizes the difficulties in obtaining an etiological 
diagnosis of expansive brain lesions in HIV-infected patients. The patient 
underwent three invasive procedures, including brain, ganglionar, and 
liver biopsies. Only the liver biopsy showed histopathological findings 
compatible with tuberculosis. Even though we were not able to confirm 
the etiology of the brain lesion, cerebral tuberculoma was the more 
likely diagnosis. 
Atypical presentations of intracranial tuberculomas can be a 
challenging diagnosis, particularly in HIV-infected patients from 
developing countries, where tuberculosis is endemic. In our case, the 
presence of disseminated disease allowed us to maintain a high index 
of diagnosis suspicion. 
Most patients with cerebral toxoplasmosis showed a CD4+ cell count 
below 100 cells/mm3, and in the case of primary CNS lymphoma, below 
50 cells/mm12,16. However, intracranial tuberculomas or tuberculous brain 
abscesses are not uncommon with CD4+ cell count above 100 cells/mm3(15). 
Cerebral toxoplasmosis lesions and tuberculomas are generally multiple, 
tuberculous brain abscesses are usually single whereas in primary CNS 
lymphoma, solitary and multiple lesions may occur at approximately the 
same frequency12. Lesions measuring more than 4 cm are more likely to 
be lymphoma, when compared with cerebral toxoplasmosis10. Similarly, 
lesions measuring more than 3 cm are more likely to be tuberculous brain 
abscesses when compared with tuberculomas1,14. The focal forms of CNS 
tuberculosis show different anatomopathological characteristics, which 
were defined by WHITENER17. Tuberculomas have a central region with 
caseous necrosis, a capsule of collagen, and giant multinuclear, epitheliod, 
and mononuclear cells. On the other hand, abscesses have to fulfill the 
following criteria: (1) macroscopic evidence of pus, (2) inflammatory 
reaction in the abscess wall, which consists of granulate vascular tissue 
and acute and chronic inflammatory cells, and (3) demonstration of 
AFB in the purulent material or in the abscess wall, or positive culture 
of M. tuberculosis.
Atypical presentation of solitary and large intracranial tuberculoma 
underscores that radiological findings are unspecific to identify etiological 
causes of focal brain lesions3,14. However, MRI is particularly useful in 
identifying the pathological stage of tuberculomas1. In our case, the MRI 
features were compatible with caseating granuloma with a solid center, 
but other neurologic diseases, including primary CNS lymphoma or 
cerebral toxoplasmosis can display similar findings. 
In the present case, the contraindication to perform lumbar puncture 
precluded the use of molecular diagnosis. Hence, pathological diagnosis 
continues to be the gold standard for a subset of HIV-infected patients 
Fig. 1 - A) A computed tomography (CT) scan of the brain revealing an irregular, solitary 
large lesion in the left fronto-temporo-parietal region, with a thick ring-enhancing pattern 
and extensive perilesional edema. B) After two months of regular treatment with first-line 
antituberculosis agents, a new CT scan showed important improvement of the lesion. 
Fig. 2 - A) A magnetic resonance imaging (MRI) showed a large expansive brain lesion with 
intermediate signal intensity and ring enhancement on T1-weighted image after gadolinium 
administration. B) MRI showed intermediate signal intensity on T2-weighted image. 
indicating absence of restricted diffusion. A stereotactic brain biopsy 
was performed. Histological examination yielded reactive gliosis and 
astrocytosis. Neither acid-fast bacilli (AFB) nor malignant cells were 
identified. Culture of brain biopsy specimens failed to show growth 
of Mycobacterium tuberculosis. Histopathological examination of an 
axillary lymphadenopathy evidenced only reactive lymphocytosis without 
identification of any microorganism. Histopathological examination 
of the liver disclosed epithelioid granulomas with caseous necrosis 
associated to chronic inflammatory infiltrate, suggestive of tuberculosis, 
however, AFB were not seen at direct microscopic examination and 
cultures were negative. Liver enzyme levels were persistently increased. 
Considering the hypothesis of disseminated tuberculosis (cerebral 
tuberculoma, hepatitis, lymphadenopathy, and pleural disease), first-
line antituberculous agents were reintroduced gradually in a sequential 
manner (rifampin, isoniazid, pyrazinamide, and etambuthol) each three 
days, without complications. After two months of regular treatment with 
isoniazid, rifampin, pyrazinamide, ethambutol, and dexamethasone, the 
systemic and neurologic alterations showed important improvement. 
Pyrazinamide and ethambutol were discontinued and the dose of 
dexamethasone was tapered in the next four weeks. The patient was 
oriented, without alteration of the level of consciousness, her speech 
was normal and she presented a mild right hemiparesis. A new CT 
scan showed important reduction of the cerebral lesion (Fig. 1B). 
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with focal brain lesions11,12,16. However, definitive diagnosis is not reached 
in as many as 8-10% of patients who undergo brain biopsy11. Since 
tuberculomas are usually firm masses, the blunt probe used in stereotactic 
biopsies may be pushed away, leading to sampling errors2.
Guidelines from the US Centers for Disease Control and Prevention 
(CDC)5 and the British Infection Society13 recommend therapy for CNS 
tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide. 
Isoniazid and rifampin are the key components of the regimen. In 
the present case, the antituberculous treatment was optimized (from 
rifampin, ethambutol, streptomycin, and ofloxacin to isoniazid, rifampin, 
ethambutol, and pyrazinamide), and important improvement of the 
CNS mass lesion was obtained, probably due to the fact that isoniazid 
penetrates the CSF freely and has potent early bactericidal activity. On the 
other hand, streptomycin does not penetrate the CSF well in the absence 
of inflammation. In addition, fluoroquinolones may represent an effective 
fourth agent, although data concerning their CSF pharmacokinetics and 
safety during prolonged therapy are limited13.
Cerebral toxoplasmosis is the most frequent expansive brain lesion 
in HIV-infected patients and its differential diagnosis is broad. In this 
context, the present case illustrates that, considering our particular 
epidemiology, where primary CNS lymphoma is rare and tuberculosis 
is frequent, a common presentation of a rare disease is less likely than a 
rare presentation of a common disease6. 
In conclusion, probable cerebral tuberculoma should always be 
considered in the differential diagnosis of solitary and large focal brain 
lesions in HIV-infected patients, particularly in patients of tuberculosis 
endemic areas and with disseminated disease. Despite extensive 
diagnostic efforts, sometimes, a trial with antituberculous therapy is a 
valuable tool to confirm the diagnosis.
RESUMO
Lesão intracraniana que respondeu ao tratamento anti-
tuberculoso em paciente infectado pelo HIV
Os tuberculomas cerebrais constituem diagnóstico diferencial 
importante da toxoplasmose cerebral em pacientes infectados pelo vírus 
da imunodeficiência humana (HIV) de países em desenvolvimento. 
Os autores relatam o caso de uma mulher HIV positiva de 34 anos 
de idade, que apresentou provável tuberculose disseminada (hepatite, 
adenomegalia, e derrame pleural) associada à lesão expansiva cerebral 
única e gigante. Apesar dos esforços diagnósticos realizados, incluindo 
biópsia cerebral, ganglionar e hepática, o diagnóstico etiológico não 
foi confirmado. Porém, a resposta clínico-radiológica ao tratamento 
tuberculostático permitiu definir o diagnóstico de tuberculoma cerebral 
e a paciente teve alta hospitalar. Apresentações atípicas de tuberculomas 
cerebrais devem ser sempre consideradas no diagnóstico diferencial das 
lesões expansivas cerebrais em pacientes infectados pelo HIV e o uso 
do tratamento tuberculostático constitui ferramenta útil na definição 
diagnóstica em um sub-grupo de pacientes. 
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